Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to our letter dated 7th November, 2022, intimating you about the earning conference call for Q2 & H1 FY23 with Analysts/Investors held on 16th November, 2022, please find attached herewith the transcript of the aforesaid conference call. The above information is also available on the website of the Company at https://www.themismedicare.com
21-11-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Audio Recording Of The Maiden Earnings Conference Call For Q2 & H1 FY23 Held On 16.11.2022

 Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that the audio recording of earnings conference call, conducted on November 16, 2022, for the quarter ended September 30, 2022, has been uploaded on the website of the Company at viz., https://www.themismedicare.com Kindly take the aforesaid on records.
16-11-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In terms of Regulations 47 of SEBI(LODR) Regulations, 2015 the company has published the Un-Audited Financial Results for the quarter and half year ended September 30,2022 in ''Indian Express'' (English) edition dated Tuesday, November 8th, 2022 & in Financials Express'' (Gujarati) edition dated Tuesday, November 8th, 2022. Further, in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in the above mentioned newspapers.
09-11-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Investor Presentation

 In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we submit herewith the Investors' Presentation of the Company, with respect to Business Overview of Themis Medicare Limited ('the Company'). Further, a copy of the same is also available on the website of the Company, viz., https://www.themismedicare.com Kindly take the above on record and acknowledge receipt of the same.
09-11-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Intimation Of The Resolution Passed By Circulation By Board Of Directors Of Themis Medicare Limited On 9Th November, 2022

 Further to our intimation about the outcome of the Board Meeting held on 7th November, 2022, we have to intimate that the Board of Directors (the Board) vide a resolution passed by circulation on 9th November, 2022 has rescinded the following resolution passed by the Board at its meeting held on 7th November, 2022 due to sudden unforeseen circumstances: Resolution authorising the Company for Purchase of 9,39,597 equity shares (representing 6.47%) of Gujarat Themis Biosyn Limited, a company listed on the BSE Limited, from Pharmaceutical Business Group [India] Limited (PBG India) at Rupees 745 per share aggregating to Rupees Seventy crores. This intimation is also being uploaded on Company's website https://www.themismedicare.com/
09-11-2022

Guj Themis Standalone September 2022 Net Sales at Rs 47.69 crore, up 36.08% Y-o-Y

 NULL
09-11-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Media Release issued by the Company on its financial results for the half year/Six months ended 30th September, 2022. This is for your information and records.
08-11-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Further to our intimation dated 7th November 2022, we wish to inform you that the earnings conference call scheduled for 9th November, 2022 stand rescheduled for Wednesday 16th November, 2022. A fresh invite for the same is attached. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com
08-11-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Result-Financial Results For September 30, 2022(Half Yearly)

 2. Unaudited Standalone and Consolidated Financial Results for the Quarter / Half year ended 30th September, 2022. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter / Half year ended 30th September, 2022 together with Limited Review Report is enclosed herewith.
07-11-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Outcome for Outcome Of Board Meeting Held On 7Th November, 2022

 1. Dr. Dinesh S. Patel has been appointed/ elected as Executive Chairman of the Company. 2. Unaudited Standalone and Consolidated Financial Results for the Quarter / Half year ended 30th September, 2022. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter / Half year ended 30th September, 2022 together with Limited Review Report is enclosed herewith. 3. Borrowing money of Rs.70 Crores (Rupees Seventy Crores only) from Non Banking Financial Companies. 4. Agreement to Sell between Themis Medicare Limited ('Company' or 'Transferor Company') and Themis Lifestyle Private Limited ('Transferee Company') 5. Purchase of up to 9,39,597 equity shares of Gujarat Themis Biosyn Limited, a company listed on the BSE Limited from Pharmaceutical Business Group [India] Limited (PBG India) ('Acquisition')
07-11-2022
Next Page
Close

Let's Open Free Demat Account